pindolol has been researched along with Ventricular Dysfunction in 1 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Ventricular Dysfunction: A condition in which HEART VENTRICLES exhibit impaired function.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dorn, GW | 1 |
| Tepe, NM | 1 |
| Wu, G | 1 |
| Yatani, A | 1 |
| Liggett, SB | 1 |
1 other study available for pindolol and Ventricular Dysfunction
| Article | Year |
|---|---|
Mechanisms of impaired beta-adrenergic receptor signaling in G(alphaq)-mediated cardiac hypertrophy and ventricular dysfunction.
Topics: Adenylyl Cyclases; Adrenergic beta-Antagonists; Animals; Cardiomegaly; GTP-Binding Protein alpha Sub | 2000 |